Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Not applicable Interventional

A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

ClinicalTrials.gov ID: NCT06639958

Public ClinicalTrials.gov record NCT06639958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 2:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Risk-Based 6MP Adherence Enhancement Strategies in Children, Adolescent and Young Adults With ALL - A Pilot Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial tests different programs to help patients with acute lymphoblastic leukemia (ALL) remember to take their medications during maintenance therapy at home. One problem with ALL maintenance treatment is remembering to take medicines at home like patients are supposed to. In maintenance, a medicine called 6-mercaptopurine or "6MP" is taken by mouth every day at home. In this study, 6MP prescriptions are filled into a special medication bottle called MEMS® which is fitted with a special cap called TrackCap™ that electronically records when the medication bottle is opened. Researchers are trying a new program to help patients be better at taking their 6MP like they're supposed to. This new program may help patients to remember to take their 6MP medication.

Study identification

NCT ID
NCT06639958
Recruitment status
Suspended
Study type
Interventional
Phase
Not applicable
Lead sponsor
Children's Oncology Group
Network
Enrollment
64 participants

Conditions and interventions

Eligibility (public fields only)

Age range
10 Years to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2024 (Actual)
Primary completion
Mar 3, 2027 (Estimated)
Completion
Mar 3, 2027 (Estimated)
Last update posted
Oct 5, 2026

2024 – 2027

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
Arkansas Children's Hospital Little Rock Arkansas 72202-3591 —
Kaiser Permanente-Oakland Oakland California 94611 —
Alfred I duPont Hospital for Children Wilmington Delaware 19803 —
Golisano Children's Hospital of Southwest Florida Fort Myers Florida 33908 —
Nemours Children's Clinic-Jacksonville Jacksonville Florida 32207 —
AdventHealth Orlando Orlando Florida 32803 —
Nemours Children's Hospital Orlando Florida 32827 —
Riley Hospital for Children Indianapolis Indiana 46202 —
Eastern Maine Medical Center Bangor Maine 04401 —
Sinai Hospital of Baltimore Baltimore Maryland 21215 —
C S Mott Children's Hospital Ann Arbor Michigan 48109 —
University Medical Center of Southern Nevada Las Vegas Nevada 89102 —
Sunrise Hospital and Medical Center Las Vegas Nevada 89109 —
Alliance for Childhood Diseases/Cure 4 the Kids Foundation Las Vegas Nevada 89135 —
Summerlin Hospital Medical Center Las Vegas Nevada 89144 —
Renown Regional Medical Center Reno Nevada 89502 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Rhode Island Hospital Providence Rhode Island 02903 —
Prisma Health Richland Hospital Columbia South Carolina 29203 —
Dell Children's Medical Center of Central Texas Austin Texas 78723 —
Methodist Children's Hospital of South Texas San Antonio Texas 78229 —
Inova Fairfax Hospital Falls Church Virginia 22042 —
Children's Hospital of The King's Daughters Norfolk Virginia 23507 —
Madigan Army Medical Center Tacoma Washington 98431 —
Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin 54301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06639958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06639958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →